Used as a key intermediate in the synthesis of anticoagulant pharmaceuticals, particularly in the development of factor Xa inhibitors. Its structure enables selective binding in biological systems, making it valuable in creating potent oral anticoagulants for preventing thrombosis. The compound's chiral center and amide ester framework contribute to high enzymatic specificity and metabolic stability, which are critical for drug efficacy and safety. It is primarily employed in research and development stages of cardiovascular medications.